Your Health, We Care

Home > Photo Wall > Honor and qualification

PIQRAY Production Approval

Release date: 2024-07-09 16:24:43     Recommended: 90

03L1076_24 阿培利司 批文_00.jpg

PIQRAY is a selective inhibitor of phosphatidylinositol-3 kinase (PI3K), mainly targeting the PI3K alpha subtype in the PI3K signaling pathway. It is used to treat specific breast diseases such as hormone receptor (HR) positivity and human epidermal growth factor receptor 2 (HER2) negativity in postmenopausal women and men.

Company News

Research News

Drug news